This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
List/tripsitting: Difference between revisions
>Graham m replace therapies with depression treatment header |
>Graham adding distinction of variant and invariant treatments and explanation about why there aren't antidotes listed for stimulants. |
||
| Line 33: | Line 33: | ||
*[[''Wabi-Sabi'']] | *[[''Wabi-Sabi'']] | ||
</li> | </li> | ||
<li class="featured list-item"> | |||
<h4 class="media-heading">Invariant addiction treatment</h4> | |||
</li> | |||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Psychedelic antidotes|Antidotes]]</h4> | <h4 class="media-heading">[[Psychedelic antidotes|Antidotes]]</h4> | ||
| Line 87: | Line 91: | ||
<h4 class="media-heading">[[Dissociative psychological first aid|Psychological first aid]]</h4> | <h4 class="media-heading">[[Dissociative psychological first aid|Psychological first aid]]</h4> | ||
*[[Immersion modifications]] | *[[Immersion modifications]] | ||
</li> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">Invariant short-term depression treatment</h4> | |||
</li> | </li> | ||
</ul> | </ul> | ||
| Line 154: | Line 161: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[GABAergic tripsitting]]</h4> | <h4 class="media-heading">[[GABAergic tripsitting]]</h4> | ||
<h4 class="media-heading">Invariant anxiety treatment</h4> | |||
*[[Anticonvulsants/antiepileptics]]: [[List_of_pharmaceuticals#Anticonvulsants/antiepileptics|Common]] | *[[Anticonvulsants/antiepileptics]]: [[List_of_pharmaceuticals#Anticonvulsants/antiepileptics|Common]] | ||
*[[Flumazenil]] (for ''[[benzodiazepine]] overdose'') | *[[Flumazenil]] (for ''[[benzodiazepine]] overdose'') | ||
| Line 163: | Line 171: | ||
*[[Naloxone]] (for ''[[opioid]] overdose'') | *[[Naloxone]] (for ''[[opioid]] overdose'') | ||
</li> | </li> | ||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 177: | Line 181: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Dealing with stimulant psychosis]]</h4> | <h4 class="media-heading">[[Dealing with stimulant psychosis]]</h4> | ||
* Cautionary note: the combination of being on dopaminergic agonists and attempting to stop their effects with dopaminergic antagonists may result in a life-threatening condition known as [https://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome neuroleptic malignant syndrome.] | |||
</li> | |||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 187: | Line 193: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[PTSD treatments|PTSD treatment]]</h4> | <h4 class="media-heading">[[PTSD treatments|PTSD treatment]]</h4> | ||
*[[MDMA-AP]] | |||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||